Detecting post-translational modification signatures as potential biomarkers in clinical mass spectrometry

R Mnatsakanyan, G Shema, M Basik… - Expert Review of …, 2018 - Taylor & Francis
Introduction: Numerous diseases are caused by changes in post-translational modifications
(PTMs). Therefore, the number of clinical proteomics studies that include the analysis of …
被引用次数：93 相关文章

Detecting post-translational modification signatures as potential biomarkers in clinical mass spectrometry.

R Mnatsakanyan, G Shema, M Basik… - Expert Review of …, 2018 - europepmc.org
Numerous diseases are caused by changes in post-translational modifications (PTMs).
Therefore, the number of clinical proteomics studies that include the analysis of PTMs is …

[引用][C] Detecting post-translational modification signatures as potential biomarkers in clinical mass spectrometry

R Mnatsakanyan, G Shema, M Basik, G Batist… - Expert Review of …, 2018 - cir.nii.ac.jp
Detecting post-translational modification signatures as potential biomarkers in clinical mass
spectrometry | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[PDF] researchgate.net

[PDF][PDF] Detecting post-translational modification signatures as potential biomarkers in clinical mass spectrometry

R Mnatsakanyan, G Shema, M Basik… - EXPERT REVIEW OF …, 2018 - researchgate.net
Introduction: Numerous diseases are caused by changes in post-translational modifications
(PTMs). Therefore, the number of clinical proteomics studies that include the analysis of …

Detecting post-translational modification signatures as potential biomarkers in clinical mass spectrometry

R Mnatsakanyan, G Shema, M Basik… - Expert review of …, 2018 - pubmed.ncbi.nlm.nih.gov
Numerous diseases are caused by changes in post-translational modifications (PTMs).
Therefore, the number of clinical proteomics studies that include the analysis of PTMs is …